Dr. Armen Yuri Gasparyan has been involved in clinical research on cardiovascular issues in inflammatory rheumatic disorders since 1994, and got his PhD degree for studies of cardiovascular involvement in familial Mediterranean fever (2002). He was a trainer of English-speaking medical students (2003-2008) and got an academic title of Associate Professor of Medicine in 2006.
He has been working as a Research Fellow in thrombosis and cardiovascular rheumatology at the Birmingham City Hospital (2007) and Departments of Rheumatology and Research & Development, Russells Hall Hospital (Teaching Trust of the University of Birmingham, UK; since 2008). As a clinical lecturer, he delivers lectures on the whole course of internal medicine and rheumatology. In 2011-2017, he developed a Special Course on Cardiovascular Rheumatology (72 academic hours of CME) and Scientific Writing and Editing (32 academic hours of CME), presented in the UK and elsewhere.
He is Honorary Professor at Shymkent State Pharmaceutical Academy (title awarded in 2017), Visiting Professor at the Kazakh National Medical University (2011-2015), Shymkent State Pharmaceutical Academy (since 2014), Samara State University (2014), Dagestan State University (2015) and Semey State Medical University (2016).
He is an expert of Scopus Content Selection & Advisory Board (since 2015).
He acted as a reviewer at The Lancet, Journal of the American College of Cardiology, Thrombosis Research, Rheumatology (Oxford), Seminars in Arthritis and Rheumatism, Arthritis Research & Therapy, Clinical Rheumatology, European Journal of Internal Medicine, Inflammation, Platelets, Therapeutics and Clinical Risk Management, Current Pharmaceutical Design and other high-impact journals.
Dr Gasparyan was Council Member of the European Association of Science Editors (2011-2014) and Chief Editor of the European Science Editing journal (2011-2014).
He was elected Adjunct Professor at the Tehran University of Medical Sciences (2010) and delivered lectures on autoinflammatory disorders and scientific writing for Iranian Rheumatology Association (2011, 2014, 2015).
He is the Editor-in-Chief of Rheumatology International (Springer Nature), Rheumatology, Immunology & Allergic Disorders and Editing, Writing & Publishing Sections Editor at the Journal of Korean Medical Science (Seoul, since 2014), Research Integrity Officer at the Mediterranean Journal of Rheumatology, Guest Editor at the Current Pharmaceutical Design (2012 and 2013) and Current Medicinal Chemistry (2014), Deputy Editor-in-Chief of Inflammation & Allergy - Drug Targets (2009-2016), Co-Editor of Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry (since 2016), Science Communication Section Editor at the Croatian Medical Journal (2013-2015), Member of Editorial Boards of Atherosclerosis, Thrombosis Research, Vascular Health & Risk Management, International Journal of the Rheumatic Diseases, Archives of Rheumatology.
He was a member of the Scientific Committees at the Excellence in Rheumatology Congress (Madrid, 2012) and Mediterranean Congress of Rheumatology (Sarajevo, 2016).
Dr Gasparyan proposed and successfully arranged Special Interest Group (SIG) sessions on research reporting and autoinflammatory disorders for the British Society of Rheumatology annual conferences (Manchester, 2015; Birmingham, 2017).
He joined the World Association of Medical Editors in 2008 and the European Association of Science Editors in 2009. And was appointed as an expert of Scopus Content Selection & Advisory Board (since 2015).
Dr Gasparyan is actively involved in the cooperation with regional rheumatology societies. He arranged scientific writing seminars for British, Greek, Croatian, Iranian, Turkish, Russian and Kazakh rheumatology societies (2011-2017).
His main research interests relate to familial Mediterranean fever, rheumatoid arthritis, platelet function, research methodology and publication ethics.
Publication record includes more than 70 MEDLINE-indexed papers on platelets in inflammation, autoinflammatory disorders, rheumatoid arthritis and science editing.